Manufactured by the Indian company, MAAN Pharmaceuticals Ltd., Ondansetron is imported in ampoules to Sri Lanka. This was followed by a subsequent decision to withhold all stocks after “continuous adverse drug reaction reports (including fatal reactions),” at the National Institute of Infectious Diseases (NIID), Angoda. This was followed by a decision on December 16th (Tuesday) to withhold all products from MAAN Pharmaceuticals until further investigations, citing continuous adverse drug reaction reports including fatal reactions. An NMRA pre-requirement was WHO-GMP standards, which MAAN Pharmaceuticals had, in addition to the audit certification by the Indian authorities,” he said. Antibiotic or antibiotic combination injections are administered in the treatment of bacterial infections.

Source: Sunday Times December 21, 2025 07:57 UTC